Leslie Brown
Medical · Norwich, CTNPI 1760790612
Payments from drug & device makers
Across 222 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$990
- Takeda Pharmaceuticals U.S.A., Inc.$410
- Bristol Myers Squibb$379
- Gilead$219
- Ironwood Pharmaceuticals, Inc$173
- plus $828 from 13 others
What the payments were for
- Food & beverage$4,060100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 59 | $1,061 |
| AbbVie | 59 | $990 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $410 |
| Bristol Myers Squibb | 22 | $379 |
| Gilead | 12 | $219 |
| Ironwood Pharmaceuticals, Inc | 8 | $173 |
| Nestle Healthcare Nutrition Inc. | 8 | $136 |
| Ardelyx, Inc. | 6 | $126 |
| Johnson & Johnson | 7 | $122 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Intercept Pharmaceuticals, Inc. | 4 | $84 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
| Sanofi | 2 | $45 |
| Pfizer | 2 | $42 |
| Boehringer Ingelheim | 2 | $35 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Novo Nordisk | 1 | $29 |
| Alfasigma USA, Inc. | 1 | $19 |
| Bausch & Lomb Americas Inc. | 1 | $14 |
How this compares
$4,060 in reported general payments places this provider in the 85th percentile of 592 medical providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 16 | $12,452 |
| Omeprazole | 39 | $666 |
| Famotidine | 30 | $635 |
| Pantoprazole Sodium | 22 | $140 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $990 | $12,45216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 592 medical providers in Connecticut.
Other medical in Norwich
- Jaclyn NeveuNorwich$8K
- Natalia FananiNorwich$7K
- Shilpa DesaiStamford$215K
- Gregory RauNew Haven$211K
- John JasinskiNorwalk$185K
- Brianna PaesanoStamford$153K
- Debra SullivanDerby$100K
- Ryan DonovanNew Haven$75K
- Jonica PagnuccoWaterbury$32K
- Alyssa GreenleafSouthington$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.